Analysts: IBM’s 2013 Will Be Messy and 2 Other Research Notes To Study

IBM (NYSE:IBM): Following weaker than expected earnings, Bernstein believes that the company’s hardware business is facing issues of competitive and secular natures. Overall, FY2013 results will be “messy,” and Bernstein keeps a Market Perform on the shares.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

IBM

ChipMOS (NASDAQ:IMOS): Craig-Hallum said a price of $40 Taiwan dollars values ChipMos shares at $33.25, and was trading at $17 in pre-open, indicating valuation upside for the company. It keeps a Buy rating and a $21 price target. 

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

IMOS

Baxter (NYSE:BAX): RBC Capital is confident that Baxter’s Gammagard will show positive results in mild Alzheimer’s patients, and therefore recommends purchasing stock prior to the late April/May Alzheimer’s top line release of the data. The company’s revenue growth should accelerate for the rest of 2013, and it keeps an Outperform rating on the stock.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

BAX

Don’t Miss: Did Amazon’s Purchase of Goodreads Come At Apple’s Expense?

More Articles About:   ,  

More from The Cheat Sheet